Advertisement

Topics

Auris Health partners with Ethicon to allow Bronchoscopic ablation of lesions in lungs

19:00 EDT 15 May 2018 | Medical Business Review

Auris Health has signed a cooperative development and commercialization agreement with NeuWave Medical, a subsidiary of Ethicon and part of the Johnson & Johnson Medical Devices Companies, to enable robotically assisted bronchoscopic ablation of lesions in the lung.

Original Article: Auris Health partners with Ethicon to allow Bronchoscopic ablation of lesions in lungs

NEXT ARTICLE

More From BioPortfolio on "Auris Health partners with Ethicon to allow Bronchoscopic ablation of lesions in lungs"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...